SAN DIEGO, CA — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance the customer experience for users of its website. “I am confident that we have found an ideal partner for […]
Göttingen, Germany Sartorius, a leading international partner of life science research and the biopharmaceutical industry, signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries. For approximately €45 million in cash, Sartorius is acquiring just over 50% of the shares of the company from its owners, […]
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK, Nov. 25, 2019 /CNW Telbec/ – Liminal BioSciences Inc. (NASDAQ:LMNL) (TSX:LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, announced today it has closed on the previously announced divestment of its Isle of Man-based bioseparations business operated […]
A consortium jointly led by Astorg and Cinven today announces that it has signed an agreement to acquire LGC, a global leader in the Life Sciences Tools sector. LGC provides a comprehensive range of measurement tools, proficiency testing schemes, supply chain assurance standards and specialty genomics reagents underpinned by leading analytical and measurement science capabilities. […]
Mt. Laurel, NJ Everingham & Kerr, Inc. announced today that Main Line Equity Partners has divested Cianflone Scientific Group (consisting of Cianflone Scientific and Tensitron; collectively “CSG”) to King Tester Corporation, a Salt Creek Capital portfolio company. Terms of the transaction were not disclosed. Founded in 1935 and headquartered in Pittsburgh, PA, CSG is a […]
QIAGEN receives several conditional, non-binding indications of interest, and decides to enter into discussions to explore potential strategic alternatives Venlo, The Netherlands – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) announces it has begun a review of potential strategic alternatives after receiving several conditional, non-binding indications of interest for the acquisition of […]
Venlo, The Netherlands – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) announces it has begun a review of potential strategic alternatives after receiving several conditional, non-binding indications of interest for the acquisition of all issued and outstanding shares of the Company. The Supervisory Board and the Management Board of QIAGEN, in […]
– Low invasiveness enables single-cell injection of target substances and extraction of intracellular materials – Tokyo, Japan Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired a nanopipette*1 technology that was developed by BioStinger, Inc., a spin-off from the University of California, Santa Cruz. This technology is able to target specific locations inside individual cells, […]
Global leader in liquid nitrogen storage systems expected to support growth, diversify revenue and reduce evo® manufacturing costs Preliminary 2020 revenue guidance of $50 – $56 Million Conference call begins today at 4:30 p.m. Eastern time BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of best-in-class […]
H2I Group announced today the acquisition of Dow Diversified Inc., a California based full service research and scientific environments specialty contractor. Dow Diversified brings over 37 years of experience in providing state of the art solutions and services for laboratories that serve clients in the western United States. LOS ANGELES — H2I Group announced today the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
